OpenAI has alleged that a former employee transferred more than 100 confidential files about an unreleased AI device to a personal account before joining Apple. The filing says information from the product was later presented to senior Apple leaders, raising the possibility that proprietary work entered Apple's product-development process.
That is an allegation, not a finding. Apple says it has policies designed to prevent employees from using a previous employer's confidential information and says it found no evidence supporting OpenAI's claim. No court has determined that Apple possessed or used OpenAI trade secrets, and the record does not establish that any disputed material appears in HomeView or another Apple product.
The dispute is unusual because Apple filed the original lawsuit in July, accusing former employees who moved to OpenAI's hardware division of taking Apple's confidential information. OpenAI denied those accusations and has now raised its own concerns within the same litigation. A federal judge granted Apple limited expedited discovery, allowing earlier access to certain devices, hiring materials and depositions.
For Apple investors, the immediate risk is legal and operational rather than financial. Discovery could expose product-development records, delay work or lead to tighter internal controls. Damages, an injunction or a product restriction would require stronger evidence and further court action.
The case is expected to continue into 2027. Until the parties produce forensic evidence, investors should separate three questions: whether files were transferred, whether Apple employees accessed them, and whether any Apple design used protected information. The current filing addresses the first question most directly and leaves the other two unresolved.